August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
David Heredia: Osimertinib + Chemotherapy Offers a Statistically Significant
Jul 22, 2025, 10:54

David Heredia: Osimertinib + Chemotherapy Offers a Statistically Significant

David Heredia, Head of Oncology Department at Punta Médica Hospital, shared on X:

“Press Release. FLAURA2 OS Results

Longer follow-up confirms that osimertinib + chemo offers a statistically significant and clinically meaningful OS benefit over osimertinib alone in 1L EGFRm NSCLC. Reinforces osimertinib as the backbone across stages. Follows the longest-reported PFS in this setting

Looking forward to seeing the full data soon!”

More posts featuring NSCLC.